pre-IPO PHARMA

COMPANY OVERVIEW

Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”).


LOCATION

  • Stockholm, , Sweden

  • THERAPEUTIC AREAS

  • Cardiovascular Disease

  • WEBSITE

    https://athera.se/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Dec 3, 2015

    Karolinska Development divests its holding in Athera Biotechnologies


    For More Press Releases


    Google Analytics Alternative